Signature symbol | Reference | Associated variables in gene selection procedure | Number of genes | |
---|---|---|---|---|
Original probes | Mapped to geneID | |||
ONC-16 | [42] | Biological knowledge; refined by patient outcome | 16 | 16 |
NKI-70 | [19] | Patient outcome | 70 | 52 |
EMC-76 | [21] | Patient outcome, stratified by estrogen receptor status | 60 + 16 | 48 + 12 |
NCH-70 | [12] | Patient outcome | 70 | 69 |
CON-52 | [43] | Patient outcome, consensus | 52 | 50 |
p53-32 | [11] | p53 mutation | 32 | 19 |
CSR | [24] | Fibroblast core serum response | 512 | 457 |
GGI-128 | [18] | Histological grade | 128 | 98 |
CCYC | [44] | Periodic expression in cell cycle progression | NA | 126 |